GLMD (Galmed Pharmaceuticals) Cyclically Adjusted Book per Share: $330.07 (As of Dec. 2025)


GLMD Galmed Pharmaceuticals Ltd GLMD
27 GF Score
Price $0.57
! 2 Warning Signs
View Full Analysis

What is Galmed Pharmaceuticals Cyclically Adjusted Book per Share?

Galmed Pharmaceuticals GLMD -11.95% 27 Cyclically Adjusted Book per Share is $330.07 as of Dec. 2025. GuruFocus rates GLMD with a GF Score™ of 27/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Galmed Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2025 was $2.398. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $330.07 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Galmed Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -12.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Galmed Pharmaceuticals was -9.80% per year. The lowest was -9.80% per year. And the median was -9.80% per year.

As of today (2026-07-03), Galmed Pharmaceuticals's current stock price is $0.5704. Galmed Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was $330.07. Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.00.


Galmed Pharmaceuticals  (NAS:GLMD) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.5704/330.07
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Galmed Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Galmed Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Chart

Galmed Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 449.45 436.83 376.55 330.07

Galmed Pharmaceuticals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 376.55 365.63 353.95 342.70 330.07

GLMD vs FBLG, SXTP, CELZ: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galmed Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Galmed Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


GLMD
27GF Score
Galmed Pharmaceuticals Ltd GLMD
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galmed Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Galmed Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=2.398/324.0540*324.0540
=2.398

Current CPI (Dec. 2025) = 324.0540.

Galmed Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201603 288.387 238.132 392.442
201606 232.677 241.018 312.839
201609 231.791 241.428 311.119
201612 165.299 241.432 221.867
201703 122.029 243.801 162.198
201706 91.794 244.955 121.435
201709 92.000 246.819 120.789
201712 197.438 246.524 259.531
201803 170.025 249.554 220.783
201806 784.853 251.989 1,009.309
201809 775.624 252.439 995.663
201812 751.231 251.233 968.979
201903 725.880 254.202 925.344
201906 695.615 256.143 880.043
201909 661.735 256.759 835.172
201912 597.034 256.974 752.883
202003 543.254 258.115 682.036
202006 507.492 257.797 637.924
202009 454.712 260.280 566.126
202012 374.178 260.474 465.512
202103 380.986 264.877 466.103
202106 323.734 271.696 386.120
202109 271.050 274.310 320.203
202112 219.403 278.802 255.014
202203 175.295 287.504 197.580
202206 149.007 296.311 162.958
202209 112.493 296.808 122.819
202212 95.879 296.797 104.684
202303 85.643 301.836 91.947
202306 75.386 305.109 80.067
202309 46.548 307.789 49.008
202312 33.045 306.746 34.910
202403 25.461 312.332 26.417
202406 22.240 314.175 22.939
202409 12.234 315.301 12.574
202412 9.806 315.605 10.069
202503 7.474 319.799 7.573
202506 3.870 322.561 3.888
202509 3.488 324.800 3.480
202512 2.398 324.054 2.398

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $330.07 mean?
Galmed Pharmaceuticals (GLMD) has a Cyclically Adjusted Book per Share of $330.07 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Galmed Pharmaceuticals and its competitors.
Is Galmed Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Galmed Pharmaceuticals' current Cyclically Adjusted Book per Share is $330.07. Overall, Galmed Pharmaceuticals has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Galmed Pharmaceuticals' Cyclically Adjusted Book per Share compare to FBLG and SXTP?
Galmed Pharmaceuticals' Cyclically Adjusted Book per Share of $330.07 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Galmed Pharmaceuticals and its competitors. Galmed Pharmaceuticals's current Cyclically Adjusted Book per Share is $330.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galmed Pharmaceuticals stock overvalued right now?
Galmed Pharmaceuticals (GLMD) has a current Cyclically Adjusted Book per Share of $330.07. The current Cyclically Adjusted Book per Share is $330.07. Galmed Pharmaceuticals' overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Galmed Pharmaceuticals (GLMD), the current Cyclically Adjusted Book per Share is $330.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galmed Pharmaceuticals Business Description

Address c/o Meitar Law Offices, 16 Abba Hillel Road, Ramat Gan, ISR, 5250608
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
27GF Score

Get the complete analysis for GLMD

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.57
Price